A look at 5 recent approvals from the US Food and Drug Administration (FDA), including treatment for systemic lupus erythematosus, a new gene therapy, and pain relief for patients with irritable bowel syndrome.
FDA approves pz-cel for recessive dystrophic epidermolysis bullosa
The decision makes pz-cel the first and only autologous cell-based gene therapy for the treatment of wounds in adult and pediatric patients with RDEB.
Food Insecurity and the Dangers of Infant Formula Dilution
Jillian Cotter, MD, MSCS, on recent advances in pediatric pneumonia management
"We've updated our internal clinical pathways to recommend 5 days for kids hospitalized with uncomplicated pneumonia," Cotter noted.
Demystifying Infant Formula
Artificial intelligence improves accuracy in estimating child abuse
New model refines prevalence estimates, reduces misdiagnoses compared to the current coding system.
Buprenorphine linked to improved outcomes for pregnant women with OUD and their infants
A recent study found reduced preterm birth, complications, and NICU use in large Tennessee Medicaid cohort.